Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
Hospitals and Health Care • 
singapore, Singapore • 21-50 Employees
Company overview
| Headquarters | singapore, Singapore |
| Phone number | +6562395097 |
| Websites | |
| NAICS | 62 |
| Founded | 2020 |
| Employees | 21-50 |
| Socials |
Key Contact at Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
Sudipto Bari
Head & Assistant Director, Translational Services & Regulatory Management
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) Email Formats
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
About Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
Cell, tissue and gene therapy (CTGT) involves the introduction of whole genetically- or non-genetically modified cells into a patient to carry out an immunotherapeutic or regenerative function to treat diseases and/or damaged organs. CTGT as witnessed by the regulatory approval of several life-saving products will be a rapidly evolving and developing field in the medical and pharmaceutical ecosystem for the years to come. To better support the growing demand for CTGT in Singapore, a new national-level organization, Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), was established on the 20th of April 2020. Formally known as National Cell Therapy Centre (working name), ACTRIS is a business unit of Consortium for Clinical Research and Innovation, Singapore (CRIS), which is a wholly owned subsidiary of Ministry of Health Holdings (MOHH). ACTRIS’s vision is to be the national and regional Centre of Excellence for facilitating discovery, process development and manufacturing of cellular-based therapeutics across the broad spectrum of immunotherapy and regenerative medicine encompassing investigational and approved CTGTs. The core capabilities of ACTRIS will include process development and validation; clinical manufacturing; product characterisation along with regulatory and clinical facilitation. ACTRIS will also provide state-of-the-art manufacturing facility, equipment, regulatory-compliant quality management system and skilled manpower to carry out the end-to-end manufacturing services for CTGTs.
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) revenue & valuation
| Annual revenue | $3,593,310 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $11,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) has 14 employees across 5 departments.
Departments
Number of employees
Funding Data
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) has never raised funding before.
Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) Tech Stack
Discover the technologies and tools that power Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
Search engines
JavaScript libraries
Miscellaneous
Security
Analytics
CDN
PaaS
Tag managers
Analytics
JavaScript libraries
Hong Kong
Australia
United States
Canada
Frequently asked questions
4.8
40,000 users
